![Robert Faulkner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Faulkner
Director/Board Member at
SALUDA MEDICAL, INC.
Net worth: 28 645 $ as of 2026-06-29
Profile
Robert Carrington Faulkner is currently Chairman at Science 37, Inc., Managing Director at Redmile Group LLC since 2008, Director at Gilda's Club New York City, Inc., Independent Director at Augmedix, Inc. since 2023, and Non-Executive Director at Saluda Medical, Inc. since 2019.
Former roles include Chairman at MedAvail Holdings, Inc. from 2022 to 2024, Managing Director at Citizens JMP Securities LLC, Director at Xeris Pharmaceuticals, Inc., Managing Director at Thomas Weisel Partners LLC from 2006 to 2008, Director at Lifesci Acquisition II Corp., Independent Director at Science 37 Holdings, Inc. from 2021 to 2024, Analyst at Prudential Securities, Principal at Wilkerson Group, Principal at Smithkline Beckman Corp, and Principal at Hambrecht & Quist LLC.
Education includes an MBA from Tuck School of Business at Dartmouth in 1990 and an undergraduate degree from Harvard College in 1984.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-12-04 | 89,883 ( 0.04% ) | 28 645 $ | 2026-06-29 |
Robert Faulkner active positions
| Companies | Position | Start |
|---|---|---|
| AUGMEDIX, INC. | Director/Board Member | 2023-04-09 |
| SALUDA MEDICAL, INC. | Director/Board Member | 2019-05-31 |
Science 37, Inc.
 Science 37, Inc. BiotechnologyHealth Technology Develops mobile technology, clinical trials and patient-centric models for clinical research | Chairman | - |
Gilda's Club New York City, Inc.
 Gilda's Club New York City, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services to cancer patients | Director/Board Member | - |
Redmile Group LLC
 Redmile Group LLC Investment ManagersFinance Redmile focuses primarily on making investments in US and non-US healthcare companies. They may also invest in fields related to healthcare where due diligence shows those healthcare assets are the driving force behind value creation and in other sectors from time to time. The firm uses fundamental research as part of their investment process. Their protocols include company financial models, market models, investment theses, and regular dialogue. Redmile’s sources include contacts with physicians, focus outside US, dialogue with companies, attendance at medical conferences; meetings with private companies, and regular dialogue within the team. | Portfolio Manager-Equities | 2008-01-31 |
Redmile Group LLC /Private Equity/
 Redmile Group LLC /Private Equity/ Investment ManagersFinance Redmile Group invests in companies located in the United States. The firm targets companies operating in the healthcare sector. It participates in early and growth stage transactions. | Private Equity Investor | 2008-01-31 |
Former positions of Robert Faulkner
| Companies | Position | End |
|---|---|---|
| MEDAVAIL HOLDINGS, INC. | Chairman | 2024-03-19 |
| SCIENCE 37 HOLDINGS, INC. | Chairman | 2024-03-11 |
Xeris Pharmaceuticals, Inc.
 Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Director/Board Member | 2018-03-31 |
| ░░░░░░ ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░ ░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Robert Faulkner
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
18
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 18 |
|---|---|
Prudential Securities
 Prudential Securities Investment Banks/BrokersFinance Provides brokerage services | Finance |
JMP Securities LLC
 JMP Securities LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
Thomas Weisel Partners LLC
 Thomas Weisel Partners LLC Regional BanksFinance Operates as an investment banking firm | Finance |
Wilkerson Group
 Wilkerson Group Medical/Nursing ServicesHealth Services Consulting services to pharmaceutical and medical products industry | Health Services |
Smithkline Beckman Corp
 Smithkline Beckman Corp Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Hambrecht & Quist LLC
 Hambrecht & Quist LLC Investment Banks/BrokersFinance Provides securities brokerage services | Finance |
Redmile Group LLC
Redmile Group LLC Investment ManagersFinance Redmile focuses primarily on making investments in US and non-US healthcare companies. They may also invest in fields related to healthcare where due diligence shows those healthcare assets are the driving force behind value creation and in other sectors from time to time. The firm uses fundamental research as part of their investment process. Their protocols include company financial models, market models, investment theses, and regular dialogue. Redmile’s sources include contacts with physicians, focus outside US, dialogue with companies, attendance at medical conferences; meetings with private companies, and regular dialogue within the team. | Finance |
Gilda's Club New York City, Inc.
Gilda's Club New York City, Inc. Miscellaneous Commercial ServicesCommercial Services Provides support services to cancer patients | Commercial Services |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Science 37, Inc.
Science 37, Inc. BiotechnologyHealth Technology Develops mobile technology, clinical trials and patient-centric models for clinical research | Health Technology |
Redmile Group LLC /Private Equity/
Redmile Group LLC /Private Equity/ Investment ManagersFinance Redmile Group invests in companies located in the United States. The firm targets companies operating in the healthcare sector. It participates in early and growth stage transactions. | Finance |
Lifesci Acquisition II Corp.
 Lifesci Acquisition II Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
MedAvail Holdings, Inc.
 MedAvail Holdings, Inc. Drugstore ChainsRetail Trade Operates as a pharmacy | Retail Trade |
Augmedix, Inc.
 Augmedix, Inc. Packaged SoftwareTechnology Services Develops AI technology to reduce the administrative burden so that clinicians can focus on what matters most–patient care | Technology Services |
Science 37 Holdings, Inc.
 Science 37 Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical research company | Commercial Services |
Saluda Medical, Inc.
 Saluda Medical, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices that develops treatments for neurological problems | Health Technology |
- Stock Market
- Insiders
- Robert Faulkner
